| Literature DB >> 32633070 |
Benedikt Mahr1, Nina Pilat1, Nicolas Granofszky1, Moritz Muckenhuber1, Lukas W Unger1, Anna M Weijler1, Mario Wiletel1, Romy Steiner1, Lisa Dorner1, Heinz Regele2, Thomas Wekerle1.
Abstract
Eliminating cytoreductive conditioning from chimerism-based tolerance protocols would facilitate clinical translation. Here we investigated the impact of major histocompatibility complex (MHC) and minor histocompatibility antigen (MiHA) barriers on mechanisms of tolerance and rejection in this setting. Transient depletion of natural killer (NK) cells at the time of bone marrow (BM) transplantation (BMT) (20 × 106 BALB/c BM cells → C57BL/6 recipients under costimulation blockade [CB] and rapamycin) prevented BM rejection. Despite persistent levels of mixed chimerism, BMT recipients gradually rejected skin grafts from the same donor strain. Extending NK cell depletion did not improve skin graft survival. However, F1 (C57BL/6×BALB/c) donors, which do not elicit NK cell-mediated rejection, induced durable chimerism and tolerance. In contrast, if F1 donors with BALB/c background only were used (BALB/c×BALB.B), no tolerance was observed. In the absence of MiHA disparities (B10.D2 donors, MHC-mismatch only), temporal NK cell depletion established stable chimerism and tolerance. Conversely, MHC identical BM (BALB.B donors, MiHA mismatch only) readily engrafted without NK cell depletion but no skin graft tolerance ensued. Therefore, we conclude that under CB and rapamycin, MHC disparities provoke NK cell-mediated BM rejection in nonirradiated recipients whereas MiHA disparities do not prevent BM engraftment but impede skin graft tolerance in established mixed chimeras.Entities:
Keywords: basic (laboratory) research/science; immunobiology; tolerance: chimerism; tolerance: costimulation blockade; tolerance: experimental; tolerance: mechanisms
Mesh:
Year: 2020 PMID: 32633070 PMCID: PMC7984377 DOI: 10.1111/ajt.16177
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086